Metastatic congenital adrenocortical carcinoma: a case report with tumor remission at 3 1/2 years.
We describe a case of metastasizing congenital adrenocortical carcinoma and a follow-up of 3 1/2 yr. Treatment with surgery and mitotane was associated with multiple complications. The patient was in remission at 3 1/2 yr. Because of the rarity of this condition, we discuss step-by-step problems encountered during management.
Godil
M A
MA
Department of Pediatrics, State University of New York, Stony Brook 11794-8111, USA.
Atlas
M P
MP
Parker
R I
RI
Priebe
C J
CJ
Zerah
M M
MM
Kane
P
P
Tsung
J
J
Wilson
T A
TA
D000306:Adrenal Cortex Neoplasms / Q000151:congenital / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007231:Infant, Newborn; D008297:Male; D008939:Mitotane / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011183:Postoperative Complications; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane; D006854:Hydrocortisone